NCT00758264View on ClinicalTrials.gov

Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

PHASE3CompletedINTERVENTIONAL
Enrollment

363

Participants

Timeline

Start Date

October 30, 2008

Primary Completion Date

June 2, 2009

Study Completion Date

November 2, 2009

Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL

Meningococcal vaccine GSK134612

Single dose intramuscular injection.

BIOLOGICAL

Pneumococcal vaccine GSK1024850A

Single dose intramuscular injection.

Trial Locations (5)

100

GSK Investigational Site, Taipei

105

GSK Investigational Site, Taipei

14000

GSK Investigational Site, Mexico City

GSK Investigational Site, México

Unknown

GSK Investigational Site, Taoyuan Hsien

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY